Cvs Health (CVS) EBIT (2009 - 2026)

Cvs Health has reported EBIT for 18 years, with the latest figure at $4.7 billion in Q1 2026.

• For the quarter ending Q1 2026, EBIT rose 800.0% year-over-year to $4.7 billion; the trailing twelve-month figure through Mar 2026 stood at $7.4 billion (up 51.5% YoY), and the FY2025 full-year result was $2.2 billion, up 3.72% from the prior year.
• EBIT for Q1 2026 stood at $4.7 billion, up from -$315.0 million in the prior quarter.
• The five-year high for EBIT was $4.7 billion in Q1 2026, with the low at -$3.9 billion in Q3 2022.
• Historically, EBIT has averaged $1.6 billion across 5 years, with a median of $755.0 million in 2024.
• Annual changes were most pronounced in 2022 — EBIT sank 1693.09% — and 2023, when it jumped 1951.19%.
• Cvs Health's EBIT stood at $3.7 billion in 2022, then dropped by 7.82% to $3.4 billion in 2023, then sank by 77.62% to $755.0 million in 2024, then plunged by 141.72% to -$315.0 million in 2025, then soared by 1585.71% to $4.7 billion in 2026.
• The last three EBIT figures came in at $4.7 billion (Q1 2026), -$315.0 million (Q4 2025), and $632.0 million (Q3 2025), per Business Quant data.